Richa Rajwanshi

Pharmacokinetics and Exposure-Response Analysis of Venetoclax + Obinutuzumab in Chronic Lymphocytic Leukemia: Phase 1b Study and Phase 3 CLL14 Trial

Divya Samineni, Leonid Gibiansky, Bei Wang, Shweta Vadhavkar et autres

fr, gb, de, us, Égypte (code pays fourni par la source)

Population Pharmacokinetics and Exposure–Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B Cell Lymphoma

Divya Samineni, Weize Huang, Leonid Gibiansky, Hao Ding et autres

fr, gb, Égypte, us (code pays fourni par la source)

Pharmacokinetics and exposure–response analysis of venetoclax+obinutuzumab in chronic lymphocytic leukaemia: phase 1b study and phase 3 CLL14 trial

Divya Samineni, Leonid Gibiansky, Bei Wang, Shweta Vadhavkar et autres

ba, us, de (code pays fourni par la source)

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant

Robert R. Redfield, Stanley C. Jordan, Stéphan Busque, Flavio Vincenti et autres

us, ch (code pays fourni par la source)

Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics

Phillip Lieberman, Ilisten Jones, Richa Rajwanshi, Karin Rosén et autres

us (code pays fourni par la source)

Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data

Maria Hoeltzenbein, Evelin Beck, Richa Rajwanshi, Carina Gøtestam Skorpen et autres

de, us, no (code pays fourni par la source)

Tocilizumab use in pregnancy: Analysis of a Global Safety Database including data from clinical trials and post-marketing data

Maria Hoeltzenbein, Evelin Beck, Richa Rajwanshi, Carina Gøtestam Skorpen et autres

de, us, no (code pays fourni par la source)

Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status–Based Treatment Stratification

Bruno C. Medeiros, Holbrook E. Kohrt, Richa Rajwanshi, Jason Gotlib et autres

us (code pays fourni par la source)

Update of a Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies

Edward D. Ball, Bruno C. Medeiros, Larissa Balaian, Tracy Roque et autres

us (code pays fourni par la source)

An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients.

Daniel A. Pollyea, Holbrook E. Kohrt, Richa Rajwanshi, Leonel Gallegos et autres

A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.

D Ball Edward, Bruno C. Medeiros, Larissa Balaian, Tracy Roque et autres

us, vn (code pays fourni par la source)

Interim results of protracted low doses of temozolomide in high-risk acute myeloid leukemia

Bruno C. Medeiros, Jason Gotlib, Steven Coutré, Cynthia C. Jones et autres